HRMY.NASDAQHarmony Biosciences Holdings, INC
Form 4: Harmony Biosciences Holdings Executive Sells Shares
Sentiment:
Insider Transaction (Form 4)
Kumar Budur, CHIEF MEDICAL OFFICER of Harmony Biosciences Holdings, Inc., sold 38,452 shares of common stock on September 16, 2026.
Summary
- Option exercise/conversion: acquired 900 Common Stock at $30.69 ($27,621) on September 16, 2026; holds 14,015 after (Direct).
- Option exercise/conversion: acquired 900 Common Stock at $30.27 ($27,243) on September 16, 2026; holds 14,915 after (Direct).
- Open-market sale: disposed of 1,800 Common Stock at $43.01 ($77,426) on September 16, 2026; holds 13,115 after (Direct).
- Option exercise/conversion: acquired 400 Common Stock at $30.69 ($12,276) on September 17, 2026; holds 13,515 after (Direct).
- Option exercise/conversion: acquired 400 Common Stock at $30.27 ($12,108) on September 17, 2026; holds 13,915 after (Direct).
- Open-market sale: disposed of 800 Common Stock at $43.00 ($34,400) on September 17, 2026; holds 13,115 after (Direct).
- Option exercise/conversion: acquired 10,406 Common Stock at $30.69 ($319,360) on September 18, 2026; holds 23,521 after (Direct).
- Option exercise/conversion: acquired 25,446 Common Stock at $30.27 ($770,250) on September 18, 2026; holds 48,967 after (Direct).
- Open-market sale: disposed of 35,852 Common Stock at $43.05 ($1,543,590) on September 18, 2026; holds 13,115 after (Direct).
- Option exercise/conversion: disposed of 900 Stock Option on September 16, 2026; holds 29,400 after (Direct).
- Option exercise/conversion: disposed of 900 Stock Option on September 16, 2026; holds 63,346 after (Direct).
- Option exercise/conversion: disposed of 400 Stock Option on September 17, 2026; holds 29,000 after (Direct).
- Option exercise/conversion: disposed of 400 Stock Option on September 17, 2026; holds 62,946 after (Direct).
- Option exercise/conversion: disposed of 10,406 Stock Option on September 18, 2026; holds 18,594 after (Direct).
- Option exercise/conversion: disposed of 25,446 Stock Option on September 18, 2026; holds 37,500 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,655,416 of stock on the open market.
Insider Transactions
Kumar Budur — Officer (CHIEF MEDICAL OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Option exercise/conversion | Common Stock | 900 | $31 | $27.6K | 14,015 |
| 2026-09-16 | Option exercise/conversion | Common Stock | 900 | $30 | $27.2K | 14,915 |
| 2026-09-16 | Open-market sale | Common Stock | 1,800 | $43 | $77.4K | 13,115 |
| 2026-09-17 | Option exercise/conversion | Common Stock | 400 | $31 | $12.3K | 13,515 |
| 2026-09-17 | Option exercise/conversion | Common Stock | 400 | $30 | $12.1K | 13,915 |
| 2026-09-17 | Open-market sale | Common Stock | 800 | $43 | $34.4K | 13,115 |
| 2026-09-18 | Option exercise/conversion | Common Stock | 10,406 | $31 | $319.4K | 23,521 |
| 2026-09-18 | Option exercise/conversion | Common Stock | 25,446 | $30 | $770.3K | 48,967 |
| 2026-09-18 | Open-market sale | Common Stock | 35,852 | $43 | $1.5M | 13,115 |
| 2026-09-16 | Option exercise/conversion | Stock Option | 900 | — | — | 29,400 |
| 2026-09-16 | Option exercise/conversion | Stock Option | 900 | — | — | 63,346 |
| 2026-09-17 | Option exercise/conversion | Stock Option | 400 | — | — | 29,000 |
| 2026-09-17 | Option exercise/conversion | Stock Option | 400 | — | — | 62,946 |
| 2026-09-18 | Option exercise/conversion | Stock Option | 10,406 | — | — | 18,594 |
| 2026-09-18 | Option exercise/conversion | Stock Option | 25,446 | — | — | 37,500 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Option exercise/conversion (900 shares) |
| 2026-09-16 | Option exercise/conversion (900 shares) |
| 2026-09-16 | Open-market sale (1,800 shares) |
| 2026-09-17 | Option exercise/conversion (400 shares) |
| 2026-09-17 | Option exercise/conversion (400 shares) |
| 2026-09-17 | Open-market sale (800 shares) |
| 2026-09-18 | Option exercise/conversion (10,406 shares) |
| 2026-09-18 | Option exercise/conversion (25,446 shares) |
| 2026-09-18 | Open-market sale (35,852 shares) |
| 2026-09-16 | Option exercise/conversion (900 shares) |
| 2026-09-16 | Option exercise/conversion (900 shares) |
| 2026-09-17 | Option exercise/conversion (400 shares) |
| 2026-09-17 | Option exercise/conversion (400 shares) |
| 2026-09-18 | Option exercise/conversion (10,406 shares) |
| 2026-09-18 | Option exercise/conversion (25,446 shares) |
Keywords
insider transaction, Form 4, HRMY, Harmony Biosciences Holdings, Inc., bearish, Kumar Budur
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.